Gelmetix Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 12

Gelmetix General Information

Description

Developer of bio-inductive gels intended to treat patients suffering from chronic lower back pain and osteoarthritis. The company's lead product is an injectable gel targeting chronic lower back pain caused by the intervertebral disc and is injected to prevent pain and restore functionality and movement into the nucleus pulposus of the disc at the early stage of its degeneration, enabling patients to relieve pain and halt the intervertebral degeneration process.

Contact Information

Website
www.gelmetix.com
Formerly Known As
Gelexir Healthcare
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Alderley Park
  • Nether Alderley SK10 4TG
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • Alderley Park
  • Nether Alderley SK10 4TG
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gelmetix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Apr-2026 Completed Pre-Clinical Trials
8. Later Stage VC (Series C) 01-May-2021 Completed Pre-Clinical Trials
7. Grant 07-Dec-2020 Completed Pre-Clinical Trials
6. Later Stage VC (Series B) 02-Apr-2020 Completed Pre-Clinical Trials
5. Grant 01-Sep-2017 Completed Pre-Clinical Trials
4. Later Stage VC (Series A) 31-May-2017 Completed Pre-Clinical Trials
3. Grant 01-Aug-2015 Completed Startup
2. Seed Round 23-Jun-2015 $1.45M $1.45M Completed Startup
1. University Spin-Out 17-Jul-2012 Completed Startup
To view Gelmetix’s complete valuation and funding history, request access »

Gelmetix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 15,314 $1.383375 $76.36 $76.36 1x $76.36 6.63%
Ordinary 2,537 $1.383375 $38.17 $38.17 1x $38.17 1.1%
To view Gelmetix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Gelmetix Patents

  • 28

    Total Documents Applications and Grants

  • Total Patents Families

  • 20

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Gelmetix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020290074-A1 Diagnosis and treatment Active 14-Jun-2019
AU-2020290074-B2 Diagnosis and treatment Active 14-Jun-2019
CA-3143127-A1 Diagnosis and treatment Pending 14-Jun-2019
EP-3982883-A1 Diagnosis and treatment Pending 14-Jun-2019
GB-201908589-D0 Diagnosis and treatment Active 14-Jun-2019 A61L27/16
To view Gelmetix’s complete patent history, request access »

Gelmetix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gelmetix Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
GC Angels Angel Group Minority
Meltwind Advisory Venture Capital Minority
RAB Capital Asset Manager Minority
Seneca Partners Merchant Banking Firm Minority
Wealth Club Corporation Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Gelmetix FAQs

  • When was Gelmetix founded?

    Gelmetix was founded in 2012.

  • Where is Gelmetix headquartered?

    Gelmetix is headquartered in Nether Alderley, United Kingdom.

  • What is the size of Gelmetix?

    Gelmetix has 9 total employees.

  • What industry is Gelmetix in?

    Gelmetix’s primary industry is Drug Discovery.

  • Is Gelmetix a private or public company?

    Gelmetix is a Private company.

  • What is Gelmetix’s current revenue?

    The current revenue for Gelmetix is .

  • How much funding has Gelmetix raised over time?

    Gelmetix has raised $16.5M.

  • Who are Gelmetix’s investors?

    GC Angels, Meltwind Advisory, RAB Capital, Seneca Partners, and Wealth Club are 5 of 12 investors who have invested in Gelmetix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process